US Stock MarketDetailed Quotes

Cartesian Therapeutics (RNAC)

Watchlist
  • 8.420
  • -0.280-3.22%
Close May 13 16:00 ET
  • 8.420
  • 0.0000.00%
Post 16:10 ET
247.39MMarket Cap-1.45P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cartesian Therapeutics (RNAC) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
-92.91%78K
-92.81%2.8M
224.77%947K
16.80%452K
-99.11%298K
-81.16%1.1M
49.64%38.91M
-109.18%-759K
-94.09%387K
537.17%33.45M
Operating revenue
-92.91%78K
-92.81%2.8M
224.77%947K
16.80%452K
-99.11%298K
-81.16%1.1M
49.64%38.91M
-109.18%-759K
-94.09%387K
537.17%33.45M
Cost of revenue
Gross profit
Operating expense
15.61%26.58M
18.97%89.5M
24.43%22.89M
19.80%21.52M
12.30%22.11M
19.81%22.99M
-32.66%75.23M
-58.09%18.39M
-8.43%17.96M
-17.58%19.69M
Selling and administrative expenses
-14.44%7.11M
4.45%31.47M
15.66%8.2M
17.59%7.72M
3.03%7.24M
-12.01%8.32M
-25.52%30.13M
-67.84%7.09M
-0.79%6.56M
15.10%7.03M
-General and administrative expense
-14.44%7.11M
4.45%31.47M
15.66%8.2M
17.59%7.72M
3.03%7.24M
-12.01%8.32M
-25.52%30.13M
-67.84%7.09M
-0.79%6.56M
15.10%7.03M
Research and development costs
32.64%19.46M
28.66%58.03M
29.92%14.69M
21.07%13.8M
17.44%14.87M
50.69%14.67M
-36.70%45.11M
-48.26%11.31M
-12.32%11.4M
-28.80%12.66M
Operating profit
-21.06%-26.5M
-138.74%-86.71M
-14.55%-21.94M
-19.86%-21.07M
-258.54%-21.81M
-63.99%-21.89M
57.62%-36.32M
46.24%-19.15M
-34.52%-17.58M
173.81%13.76M
Net non-operating interest income expense
-10.93%6.58M
-48.33%1.27M
-39.84%1.55M
46.28%1.75M
246.60%7.39M
-50.56%2.45M
302.12%2.57M
258.91%1.2M
Non-operating interest income
----
-10.93%6.58M
-48.33%1.27M
-39.84%1.55M
46.28%1.75M
----
48.79%7.39M
--2.45M
--2.57M
--1.2M
Non-operating interest expense
----
----
----
----
----
----
--0
--0
--0
--0
Other net income (expense)
-403.49%-12.68M
-23.16%-59.37M
-1,304.66%-81.1M
-78.46%-16.38M
3,321.24%35.95M
109.61%4.18M
68.93%-48.21M
104.06%6.73M
-272.06%-9.18M
-113.94%-1.12M
Gain on sale of security
-70.78%1.12M
185.30%3.7M
388.57%707K
-90.90%516K
116.73%654K
181.83%3.83M
96.83%-4.33M
99.83%-245K
11.53%5.67M
-150.37%-3.91M
Special income (charges)
-4,088.44%-13.8M
-37.26%-61.05M
-1,175.33%-79.8M
-11.92%-16.9M
1,312.00%35.3M
100.88%346K
-133.98%-44.48M
139.04%7.42M
---15.1M
--2.5M
-Less：Restructuring and merger&acquisition
4,088.44%13.8M
-88.20%4.35M
254.00%23.1M
11.92%16.9M
-1,312.00%-35.3M
-100.88%-346K
101.64%36.9M
-181.97%-15M
--15.1M
---2.5M
-Less:Impairment of capital assets
----
648.12%56.7M
----
----
----
----
967.46%7.58M
----
----
----
Other non- operating income (expenses)
---3K
-431.68%-2.01M
-351.58%-2.01M
----
-101.71%-5K
----
-12.30%606K
-616.13%-444K
-1.19%250K
19.18%292K
Income before tax
-121.24%-39.18M
-80.84%-139.5M
-921.16%-101.77M
-48.46%-35.9M
14.82%15.89M
68.83%-17.71M
67.69%-77.14M
94.93%-9.97M
-168.64%-24.18M
221.51%13.84M
Income tax
-3,303.14%-9.19M
101.51%287K
Net income
-121.24%-39.18M
-68.30%-130.3M
-802.92%-92.58M
-48.46%-35.9M
14.82%15.89M
68.83%-17.71M
64.76%-77.42M
94.23%-10.25M
-168.64%-24.18M
221.51%13.84M
Net income continuous Operations
-121.24%-39.18M
-68.30%-130.3M
-802.92%-92.58M
-48.46%-35.9M
14.82%15.89M
68.83%-17.71M
64.76%-77.42M
94.23%-10.25M
-168.64%-24.18M
221.51%13.84M
Minority interest income
Net income attributable to the parent company
-121.24%-39.18M
-68.30%-130.3M
-802.92%-92.58M
-48.46%-35.9M
14.82%15.89M
68.83%-17.71M
64.76%-77.42M
94.23%-10.25M
-168.64%-24.18M
221.51%13.84M
Preferred stock dividends
Other preferred stock dividends
-37.55%2.63M
0
4.21M
Net income attributable to common stockholders
-121.24%-39.18M
-68.30%-130.3M
-802.92%-92.58M
-48.46%-35.9M
37.70%13.26M
68.83%-17.71M
69.90%-77.42M
95.24%-10.25M
-168.64%-24.18M
184.55%9.63M
Basic earnings per share
-114.71%-1.46
-12.05%-5.02
-2,846.15%-3.57
-22.12%-1.38
-12.07%0.51
93.52%-0.68
91.00%-4.48
100.31%0.13
35.06%-1.13
126.01%0.58
Diluted earnings per share
-114.71%-1.46
-11.80%-5.02
-3,075.00%-3.57
-22.12%-1.38
-7.41%0.5
93.52%-0.68
90.98%-4.49
100.29%0.12
35.06%-1.13
124.22%0.54
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue -92.91%78K-92.81%2.8M224.77%947K16.80%452K-99.11%298K-81.16%1.1M49.64%38.91M-109.18%-759K-94.09%387K537.17%33.45M
Operating revenue -92.91%78K-92.81%2.8M224.77%947K16.80%452K-99.11%298K-81.16%1.1M49.64%38.91M-109.18%-759K-94.09%387K537.17%33.45M
Cost of revenue
Gross profit
Operating expense 15.61%26.58M18.97%89.5M24.43%22.89M19.80%21.52M12.30%22.11M19.81%22.99M-32.66%75.23M-58.09%18.39M-8.43%17.96M-17.58%19.69M
Selling and administrative expenses -14.44%7.11M4.45%31.47M15.66%8.2M17.59%7.72M3.03%7.24M-12.01%8.32M-25.52%30.13M-67.84%7.09M-0.79%6.56M15.10%7.03M
-General and administrative expense -14.44%7.11M4.45%31.47M15.66%8.2M17.59%7.72M3.03%7.24M-12.01%8.32M-25.52%30.13M-67.84%7.09M-0.79%6.56M15.10%7.03M
Research and development costs 32.64%19.46M28.66%58.03M29.92%14.69M21.07%13.8M17.44%14.87M50.69%14.67M-36.70%45.11M-48.26%11.31M-12.32%11.4M-28.80%12.66M
Operating profit -21.06%-26.5M-138.74%-86.71M-14.55%-21.94M-19.86%-21.07M-258.54%-21.81M-63.99%-21.89M57.62%-36.32M46.24%-19.15M-34.52%-17.58M173.81%13.76M
Net non-operating interest income expense -10.93%6.58M-48.33%1.27M-39.84%1.55M46.28%1.75M246.60%7.39M-50.56%2.45M302.12%2.57M258.91%1.2M
Non-operating interest income -----10.93%6.58M-48.33%1.27M-39.84%1.55M46.28%1.75M----48.79%7.39M--2.45M--2.57M--1.2M
Non-operating interest expense --------------------------0--0--0--0
Other net income (expense) -403.49%-12.68M-23.16%-59.37M-1,304.66%-81.1M-78.46%-16.38M3,321.24%35.95M109.61%4.18M68.93%-48.21M104.06%6.73M-272.06%-9.18M-113.94%-1.12M
Gain on sale of security -70.78%1.12M185.30%3.7M388.57%707K-90.90%516K116.73%654K181.83%3.83M96.83%-4.33M99.83%-245K11.53%5.67M-150.37%-3.91M
Special income (charges) -4,088.44%-13.8M-37.26%-61.05M-1,175.33%-79.8M-11.92%-16.9M1,312.00%35.3M100.88%346K-133.98%-44.48M139.04%7.42M---15.1M--2.5M
-Less：Restructuring and merger&acquisition 4,088.44%13.8M-88.20%4.35M254.00%23.1M11.92%16.9M-1,312.00%-35.3M-100.88%-346K101.64%36.9M-181.97%-15M--15.1M---2.5M
-Less:Impairment of capital assets ----648.12%56.7M----------------967.46%7.58M------------
Other non- operating income (expenses) ---3K-431.68%-2.01M-351.58%-2.01M-----101.71%-5K-----12.30%606K-616.13%-444K-1.19%250K19.18%292K
Income before tax -121.24%-39.18M-80.84%-139.5M-921.16%-101.77M-48.46%-35.9M14.82%15.89M68.83%-17.71M67.69%-77.14M94.93%-9.97M-168.64%-24.18M221.51%13.84M
Income tax -3,303.14%-9.19M101.51%287K
Net income -121.24%-39.18M-68.30%-130.3M-802.92%-92.58M-48.46%-35.9M14.82%15.89M68.83%-17.71M64.76%-77.42M94.23%-10.25M-168.64%-24.18M221.51%13.84M
Net income continuous Operations -121.24%-39.18M-68.30%-130.3M-802.92%-92.58M-48.46%-35.9M14.82%15.89M68.83%-17.71M64.76%-77.42M94.23%-10.25M-168.64%-24.18M221.51%13.84M
Minority interest income
Net income attributable to the parent company -121.24%-39.18M-68.30%-130.3M-802.92%-92.58M-48.46%-35.9M14.82%15.89M68.83%-17.71M64.76%-77.42M94.23%-10.25M-168.64%-24.18M221.51%13.84M
Preferred stock dividends
Other preferred stock dividends -37.55%2.63M04.21M
Net income attributable to common stockholders -121.24%-39.18M-68.30%-130.3M-802.92%-92.58M-48.46%-35.9M37.70%13.26M68.83%-17.71M69.90%-77.42M95.24%-10.25M-168.64%-24.18M184.55%9.63M
Basic earnings per share -114.71%-1.46-12.05%-5.02-2,846.15%-3.57-22.12%-1.38-12.07%0.5193.52%-0.6891.00%-4.48100.31%0.1335.06%-1.13126.01%0.58
Diluted earnings per share -114.71%-1.46-11.80%-5.02-3,075.00%-3.57-22.12%-1.38-7.41%0.593.52%-0.6890.98%-4.49100.29%0.1235.06%-1.13124.22%0.54
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -